Duloxetine/pregabalin

度洛西汀/普瑞巴林

Report date: 2026/04/03 20:03:44

Base Information

Drug NameDuloxetine/pregabalin

Drug Alias NameN0750N-0750

ClassificationSmall molecules

Mechanisms of ActionSerotonin transporter inhibitorsNorepinephrine transporter inhibitorsVoltage-gated calcium channel alpha2/delta subunit 1 blockers

TargetsNorepinephrine transporterSerotonin transporterVoltage-gated calcium channel alpha2/delta subunit 1

Therapy Area/IndicationsDiabetic Neuropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBrazil

CombinationsYes Duloxetine Hydrochloride Pregabalin

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesEurofarma Laboratorios Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEurofarma Laboratorios Sa

Active IndicationsN/A

Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A